Werewolf Therapeutics (HOWL) Earnings Date & Reports
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
HOWL is expected to report earnings to rise 6.50% to -42 cents per share on November 06
Q3'25
Est.
$-0.43
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.04
Q3'24
Beat
by $0.03
The last earnings report on August 14 showed earnings per share of -40 cents, beating the estimate of -46 cents. With 133.85K shares outstanding, the current market capitalization sits at 59.23M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HOWL showed earnings on August 14, 2025. You can read more about the earnings report here.